Adagio Medical Holdings, Inc Common Stock Cash Flow Conversion Efficiency
Adagio Medical Holdings, Inc Common Stock cash flow conversion efficiency. Based on the latest financial reports, Adagio Medical Holdings, Inc Common Stock (ADGM) has a cash flow conversion efficiency ratio of 12.675x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.26 Million) by net assets ($-415.00K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Adagio Medical Holdings, Inc Common Stock (2021–2025)
Cash flow conversion efficiency of Adagio Medical Holdings, Inc Common Stock from 2021 to 2025. This chart illustrates how Adagio Medical Holdings, Inc Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Adagio Medical Holdings, Inc Common Stoc share price for real-time trading data and today's change.
Adagio Medical Holdings, Inc Common Stock Cash Flow Conversion Ratio Explained
Adagio Medical Holdings, Inc Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Adagio Medical Holdings, Inc Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Adagio Medical Holdings, Inc Common Stock ranked by their cash flow conversion efficiency. Also see Adagio Medical Holdings, Inc Common Stoc (ADGM) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
UIL Ltd
LSE:UTL
|
0.057x |
|
Hall of Fame Resort Entertainment Co
NASDAQ:HOFV
|
-0.053x |
|
Tristel
LSE:TSTL
|
0.161x |
|
Eleco PLC
LSE:ELCO
|
0.222x |
|
Synthomer plc
LSE:SYNT
|
0.005x |
|
paragon GmbH & Co. KGaA
F:PGN
|
0.013x |
|
BLUEBIRD MERCH.VENT. LTD.
F:09D
|
N/A |
|
Kontrol Energy Corp
NEO:KNR
|
-0.005x |
Annual Cash Flow Conversion Efficiency for Adagio Medical Holdings, Inc Common Stock (2021–2025)
The table below shows the annual cash flow conversion efficiency of Adagio Medical Holdings, Inc Common Stock from 2021 to 2025. Review how financially flexible is Adagio Medical Holdings, Inc Common Stoc to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $12.40 Million | $-19.01 Million | -1.533x | -3.63% |
| 2024-12-31 | $19.91 Million | $-29.46 Million | -1.479x | -27009.22% |
| 2023-12-31 | $-132.02 Million | $-725.86K | 0.005x | -97.65% |
| 2022-12-31 | $-95.88 Million | $-22.41 Million | 0.234x | -12.08% |
| 2021-12-31 | $-72.62 Million | $-19.31 Million | 0.266x | -- |
About Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLA… Read more